Aug 2, 2017 by Motley Fool Staff3 Exciting Biotechs Under $30: Zogenix's Drug Gives New Hope for Rare IndicationZogenix is working on a drug that could help treat a heretofore untreatable indication, and trial results so far are good.
Aug 2, 2017 by Motley Fool Staff3 Exciting Biotechs Under $30: Flexion Therapeutics' Response to the Opioid EpidemicOpioid addiction is an epidemic, and Flexion is pretty far along with what looks like a promising treatment for joint pain sufferers.
Aug 1, 2017 by Motley Fool StaffHere's Why Tractor Supply Company Shareholders Are SmilingThe rural brick-and-mortar retailer operates in an e-commerce resistant niche, and its results show it.
Aug 1, 2017 by Motley Fool StaffPayPal Beats Expectations Again -- As It Has Every QuarterAnd it added new customers faster than it had in quite some time.
Aug 1, 2017 by Motley Fool StaffIs Anything Going Right for Buffalo Wild Wings?Second-quarter profits missed the mark for a number of reasons, continuing a painful trend that began a year and half ago.
Jul 31, 2017 by Motley Fool StaffHow Chipotle's Leadership Disappointed on Its Earnings CallThe second-quarter numbers were OK, and guidance held steady, but the CEO appears to still be in denial about the fast-casual restaurant chain’s issues.
Jul 31, 2017 by Motley Fool StaffIconic U.S. Companies Delivered Earnings Beats -- but Not All Got Stock BumpsFord, AT&T, U.S. Steel, Hershey, and Coca-Cola all outperformed strong last quarter. Only two of the five did so in the market on Wednesday.
Jul 31, 2017 by Motley Fool StaffHow Did Boeing Fly So Far Above Profit Expectations for Q2?The aerospace giant raised guidance too, and its gains on the day kept the whole Dow airborne.
Jul 31, 2017 by Motley Fool StaffDomino's Same-Store Sales Story Is a Tale of Two PiesIn the U.S., second-quarter comps growth was a phenomenal 11%. Internationally, though, results were less impressive.
Jul 31, 2017 by Motley Fool StaffAlphabet Isn't Quite Clicking on All CylindersYes, revenue is rising at a furious pace. But there’s a price to be paid for that -- literally -- and the company is paying it.
Jul 31, 2017 by Motley Fool StaffThe Wild Reason McDonald’s Shares Hit a New High Last WeekSame-store sales globally last quarter were up 6.5%, which is completely insane.
Jul 30, 2017 by Motley Fool StaffThe 4 Payments Companies Jason Moser Is Buying for the War on CashThe credit card and digital-payments spaces have huge potential for growth.
Jul 30, 2017 by Motley Fool StaffBlue Apron Got a Triple Upgrade From AnalystsAnd the stock, which has been tanking consistently since its recent IPO, took a substantial bounce.
Jul 30, 2017 by Motley Fool StaffWhy the Market Toyed With Hasbro After a Solid Earnings BeatProfit and revenue exceeded expectations, so what drove the stock down 10%?
Jul 30, 2017 by Motley Fool StaffKKR's Buyout of WebMD Is Part of a Big, Long-Term TrendIt’s yet another acquisition of a public company by a private equity firm, and the reasons that can benefit both only grow more compelling.
Jul 29, 2017 by Motley Fool StaffThe Biggest Risks With ShopifyShopify has seen huge growth in the past few years and could see even more -- but it’s not without significant risks.
Jul 29, 2017 by Motley Fool StaffShopify Is Just Scratching the SurfaceDespite an impressive 175% run-up in the past 12 months, Shopify still has plenty of room to grow.
Jul 29, 2017 by Motley Fool StaffWhat's Behind Shopify's 175% Surge in the Past 12 MonthsWhat Shopify does, and how it does it so well that it's seen such non-stop growth since its IPO.
Jul 26, 2017 by Motley Fool StaffWhy Oil Is at a 6-Week HighOil types across the board are trading up this week on recent reports of inventory draws out of Cushing.
Jul 26, 2017 by Motley Fool StaffCSX Rail Down 5% on Shocking Conference CallA CEO departure and plans for mass layoffs are just the tip of the iceberg for CSX’s disastrous quarterly earnings call.
